S&P 500   2,631.32 (-99.06%)
DOW   22,400.02 (+0.32%)
QQQ   193.26 (+0.64%)
AAPL   259.24 (+1.74%)
FB   169.30 (+2.02%)
MSFT   161.36 (+0.71%)
GOOGL   1,167.13 (+1.82%)
NVDA   268.65 (+1.15%)
BABA   195.96 (+2.45%)
MU   44.73 (+0.45%)
GE   8.06 (+2.15%)
TSLA   535.75 (+6.70%)
T   29.73 (-1.65%)
ACB   0.94 (+5.60%)
F   5.11 (+1.59%)
NFLX   378.72 (+2.09%)
BAC   22.24 (+0.91%)
GILD   75.20 (-0.96%)
DIS   101.26 (+1.46%)
S&P 500   2,631.32 (-99.06%)
DOW   22,400.02 (+0.32%)
QQQ   193.26 (+0.64%)
AAPL   259.24 (+1.74%)
FB   169.30 (+2.02%)
MSFT   161.36 (+0.71%)
GOOGL   1,167.13 (+1.82%)
NVDA   268.65 (+1.15%)
BABA   195.96 (+2.45%)
MU   44.73 (+0.45%)
GE   8.06 (+2.15%)
TSLA   535.75 (+6.70%)
T   29.73 (-1.65%)
ACB   0.94 (+5.60%)
F   5.11 (+1.59%)
NFLX   378.72 (+2.09%)
BAC   22.24 (+0.91%)
GILD   75.20 (-0.96%)
DIS   101.26 (+1.46%)
S&P 500   2,631.32 (-99.06%)
DOW   22,400.02 (+0.32%)
QQQ   193.26 (+0.64%)
AAPL   259.24 (+1.74%)
FB   169.30 (+2.02%)
MSFT   161.36 (+0.71%)
GOOGL   1,167.13 (+1.82%)
NVDA   268.65 (+1.15%)
BABA   195.96 (+2.45%)
MU   44.73 (+0.45%)
GE   8.06 (+2.15%)
TSLA   535.75 (+6.70%)
T   29.73 (-1.65%)
ACB   0.94 (+5.60%)
F   5.11 (+1.59%)
NFLX   378.72 (+2.09%)
BAC   22.24 (+0.91%)
GILD   75.20 (-0.96%)
DIS   101.26 (+1.46%)
S&P 500   2,631.32 (-99.06%)
DOW   22,400.02 (+0.32%)
QQQ   193.26 (+0.64%)
AAPL   259.24 (+1.74%)
FB   169.30 (+2.02%)
MSFT   161.36 (+0.71%)
GOOGL   1,167.13 (+1.82%)
NVDA   268.65 (+1.15%)
BABA   195.96 (+2.45%)
MU   44.73 (+0.45%)
GE   8.06 (+2.15%)
TSLA   535.75 (+6.70%)
T   29.73 (-1.65%)
ACB   0.94 (+5.60%)
F   5.11 (+1.59%)
NFLX   378.72 (+2.09%)
BAC   22.24 (+0.91%)
GILD   75.20 (-0.96%)
DIS   101.26 (+1.46%)
Log in

NYSE:CC - Chemours Stock Price, Forecast & News

$9.33
-0.36 (-3.72 %)
(As of 03/31/2020 11:56 AM ET)
Today's Range
$8.95
Now: $9.33
$9.71
50-Day Range
$8.21
MA: $13.69
$19.70
52-Week Range
$8.01
Now: $9.33
$41.60
Volume306,472 shs
Average Volume4.34 million shs
Market Capitalization$1.53 billion
P/E RatioN/A
Dividend Yield10.52%
Beta2.2
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Read More
Chemours logo

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
CUSIPN/A
Phone302-773-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.53 billion
Cash Flow$4.44 per share
Book Value$4.25 per share

Profitability

Net Income$-52,000,000.00

Miscellaneous

Employees7,000
Market Cap$1.53 billion
Next Earnings Date5/7/2020 (Estimated)
OptionableOptionable

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.


Chemours (NYSE:CC) Frequently Asked Questions

How has Chemours' stock been impacted by COVID-19 (Coronavirus)?

Chemours' stock was trading at $10.66 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CC stock has decreased by 12.5% and is now trading at $9.33. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Chemours?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 8 hold ratings, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Chemours.

When is Chemours' next earnings date?

Chemours is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for Chemours.

How were Chemours' earnings last quarter?

Chemours Co (NYSE:CC) released its quarterly earnings data on Thursday, February, 13th. The specialty chemicals company reported $0.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.14. The specialty chemicals company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.37 billion. Chemours had a positive return on equity of 52.65% and a negative net margin of 0.92%. View Chemours' earnings history.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours announced a quarterly dividend on Wednesday, February 12th. Stockholders of record on Thursday, February 27th will be given a dividend of $0.25 per share on Monday, March 16th. This represents a $1.00 annualized dividend and a yield of 10.72%. The ex-dividend date of this dividend is Wednesday, February 26th. View Chemours' dividend history.

What guidance has Chemours issued on next quarter's earnings?

Chemours issued an update on its FY20 earnings guidance on Thursday, February, 13th. The company provided EPS guidance of $2.60-$3.55 for the period, compared to the Thomson Reuters consensus estimate of $3.22.

What price target have analysts set for CC?

12 brokers have issued 1-year price targets for Chemours' stock. Their forecasts range from $10.00 to $42.00. On average, they anticipate Chemours' stock price to reach $19.95 in the next year. This suggests a possible upside of 113.8% from the stock's current price. View analysts' price targets for Chemours.

Has Chemours been receiving favorable news coverage?

Media coverage about CC stock has trended very positive on Tuesday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Chemours earned a news sentiment score of 3.2 on InfoTrie's scale. They also assigned headlines about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutChemours.

Are investors shorting Chemours?

Chemours saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 16,479,800 shares, an increase of 10.5% from the February 27th total of 14,910,000 shares. Based on an average daily volume of 3,190,000 shares, the short-interest ratio is presently 5.2 days. Approximately 10.2% of the shares of the company are sold short. View Chemours' Current Options Chain.

Who are some of Chemours' key competitors?

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include E I Du Pont De Nemours And Co (DD), Micron Technology (MU), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Energy Transfer LP Unit (ET), Alibaba Group (BABA), Pfizer (PFE), Intel (INTC) and Johnson & Johnson (JNJ).

Who are Chemours' key executives?

Chemours' management team includes the following people:
  • Mr. Mark P. Vergnano, Pres, CEO & Director (Age 61)
  • Mr. Mark E. Newman, Sr. VP & CFO (Age 56)
  • Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 62)
  • Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 55)

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

How do I buy shares of Chemours?

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $9.33.

How big of a company is Chemours?

Chemours has a market capitalization of $1.53 billion and generates $5.53 billion in revenue each year. The specialty chemicals company earns $-52,000,000.00 in net income (profit) each year or $2.51 on an earnings per share basis. Chemours employs 7,000 workers across the globe. View additional information about Chemours.

What is Chemours' official website?

The official website for Chemours is http://www.chemours.com/.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]


MarketBeat Community Rating for Chemours (NYSE CC)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  586 (Vote Outperform)
Underperform Votes:  656 (Vote Underperform)
Total Votes:  1,242
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel